157 related articles for article (PubMed ID: 37736067)
1. Incorporating Genetic Testing Into the Care of Patients With Amyotrophic Lateral Sclerosis/Frontotemporal Degeneration Spectrum Disorders.
Chambers C; Lichten L; Crook A; Uhlmann WR; Dratch L
Neurol Clin Pract; 2023 Oct; 13(5):e200201. PubMed ID: 37736067
[TBL] [Abstract][Full Text] [Related]
2. Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy.
Casterton RL; Hunt RJ; Fanto M
J Mol Biol; 2020 Apr; 432(8):2692-2713. PubMed ID: 32119873
[TBL] [Abstract][Full Text] [Related]
3. Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia.
Yang X; Sun X; Liu Q; Liu L; Li J; Cai Z; Zhang K; Liu S; He D; Shen D; Liu M; Cui L; Zhang X
Orphanet J Rare Dis; 2022 Nov; 17(1):404. PubMed ID: 36345033
[TBL] [Abstract][Full Text] [Related]
4. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management.
Roggenbuck J; Fong JC
Clin Lab Med; 2020 Sep; 40(3):271-287. PubMed ID: 32718499
[TBL] [Abstract][Full Text] [Related]
5. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
[TBL] [Abstract][Full Text] [Related]
6. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
Cui R; Tuo M; Li P; Zhou C
Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
[TBL] [Abstract][Full Text] [Related]
7. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
8. SQSTM1 variant in disorders of the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: identification of a novel heterozygous variant and a review of the literature.
Li W; Gao H; Dong X; Zheng D
J Neurol; 2021 Apr; 268(4):1351-1357. PubMed ID: 33125541
[TBL] [Abstract][Full Text] [Related]
9. Toward genetic counseling practice standards for diagnostic testing in amyotrophic lateral sclerosis and frontotemporal dementia.
Crook A; Jacobs C; Newton-John T; McEwen A
Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):562-574. PubMed ID: 35343344
[No Abstract] [Full Text] [Related]
10. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
11. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Davidson JM; Chung RS; Lee A
Neurobiol Dis; 2022 May; 166():105653. PubMed ID: 35143965
[TBL] [Abstract][Full Text] [Related]
12. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
[TBL] [Abstract][Full Text] [Related]
13. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72.
Snowden JS; Harris J; Richardson A; Rollinson S; Thompson JC; Neary D; Mann DM; Pickering-Brown S
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):172-6. PubMed ID: 23421625
[TBL] [Abstract][Full Text] [Related]
15. Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach.
Ahmed RM; Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD
Brain Commun; 2021; 3(4):fcab257. PubMed ID: 34805999
[TBL] [Abstract][Full Text] [Related]
16. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.
Le Ber I; Camuzat A; Guillot-Noel L; Hannequin D; Lacomblez L; Golfier V; Puel M; Martinaud O; Deramecourt V; Rivaud-Pechoux S; Millecamps S; Vercelletto M; Couratier P; Sellal F; Pasquier F; Salachas F; Thomas-Antérion C; Didic M; Pariente J; Seilhean D; Ruberg M; Wargon I; Blanc F; Camu W; Michel BF; Berger E; Sauvée M; Thauvin-Robinet C; Mondon K; Tournier-Lasserve E; Goizet C; Fleury M; Viennet G; Verpillat P; Meininger V; Duyckaerts C; Dubois B; Brice A
J Alzheimers Dis; 2013; 34(2):485-99. PubMed ID: 23254636
[TBL] [Abstract][Full Text] [Related]
17. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuum.
Masuda M; Senda J; Watanabe H; Epifanio B; Tanaka Y; Imai K; Riku Y; Li Y; Nakamura R; Ito M; Ishigaki S; Atsuta N; Koike H; Katsuno M; Hattori N; Naganawa S; Sobue G
Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):571-579. PubMed ID: 27684890
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Immune Activation by
Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
Ugbode C; West RJH
Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
